Related content

Comparison between cisplatin plus vinorelbine and cisplatin plus docetaxel in the treatment of advanced nonsmallcell lung cancer: A metaanalysis of randomized controlled trials

By              

Molecular and Clinical Oncology, Vol. 2, Iss. 1, 2014-01 ,pp. : 146-150

Spandidos Publications

Access to resources Recommend Favorite

Current and Emerging Treatment Options for Castration-Resistant Prostate Cancer: A Focus on Immunotherapy

By Gerritsen Winald   Sharma Padmanee  

Journal of Clinical Immunology, Vol. 32, Iss. 1, 2012-02 ,pp. : 25-35

Springer Publishing Company

Access to resources Recommend Favorite

Targeting castration-resistant prostate cancer with monoclonal antibodies and constructs

By Slovin Susan F  

Immunotherapy, Vol. 5, Iss. 12, 2013-12 ,pp. : 1347-1355

Future Medicine

Access to resources Recommend Favorite

A metaanalysis of randomized controlled trials comparing early and late concurrent thoracic radiotherapy with etoposide and cisplatin/carboplatin chemotherapy for limiteddisease smallcell lung cancer

By          

Molecular and Clinical Oncology, Vol. 2, Iss. 5, 2014-01 ,pp. : 805-810

Spandidos Publications

Access to resources Recommend Favorite

The prognostic significance of loss of the androgen receptor and neuroendocrine differentiation in prostate biopsy specimens among castration-resistant prostate cancer patients

By Komiya  

Molecular and Clinical Oncology, Vol. 1, Iss. 2, 2013-01 ,pp. : 257-262

Spandidos Publications

Access to resources Recommend Favorite